Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara Iyengar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Gastroenterology|November 26, 2009
What's causing this woman's chest pain?Tara Iyengar, Ramesh K Ramanathan, Philip J Gold
Pediatric Annals|April 10, 2023
Pediatric Cardiac Emergencies: When to Worry and When to ReassureChukwuemeka Igwe, Tara Iyengar, Alisa McQueen, et al.
Journal of the American Heart Association|August 19, 2024
Disparities in Prenatal Diagnosis of Congenital Heart Defects: The Interplay of Insurance and UrbanicityJoyce L Woo, Rupali Gandhi, Tara Iyengar, et al.
Prenatal Diagnosis|September 23, 2024
Second-Trimester Ultrasound Receipt Mediates the Relationship Between Public Insurance and Prenatal Diagnosis of a Congenital Heart DefectJoyce L Woo, Rupali Gandhi, Christina Laternser, et al.
Investigational New Drugs|April 12, 2012
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancerGlen J Weiss, Ross C Donehower, Tara Iyengar, et al.
Prenatal Diagnosis|December 18, 2023
Patient-reported barriers to prenatal diagnosis of congenital heart defects: A mixed-methods studyJoyce L Woo, Shelvonne Burton, Tara Iyengar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Gastroenterology|November 26, 2009
What's causing this woman's chest pain?Tara Iyengar, Ramesh K Ramanathan, Philip J Gold
Pediatric Annals|April 10, 2023
Pediatric Cardiac Emergencies: When to Worry and When to ReassureChukwuemeka Igwe, Tara Iyengar, Alisa McQueen, et al.
Journal of the American Heart Association|August 19, 2024
Disparities in Prenatal Diagnosis of Congenital Heart Defects: The Interplay of Insurance and UrbanicityJoyce L Woo, Rupali Gandhi, Tara Iyengar, et al.
Prenatal Diagnosis|September 23, 2024
Second-Trimester Ultrasound Receipt Mediates the Relationship Between Public Insurance and Prenatal Diagnosis of a Congenital Heart DefectJoyce L Woo, Rupali Gandhi, Christina Laternser, et al.
Investigational New Drugs|April 12, 2012
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancerGlen J Weiss, Ross C Donehower, Tara Iyengar, et al.
Prenatal Diagnosis|December 18, 2023
Patient-reported barriers to prenatal diagnosis of congenital heart defects: A mixed-methods studyJoyce L Woo, Shelvonne Burton, Tara Iyengar, et al.
Pageof 1